MedTrace Logo

A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

NCT01279785 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-11-25

No results posted yet for this study

Summary

This is a single arm, open label study of up to 20 patients with prostate cancer scheduled for prostatectomy at the NIH Clinical Center. 123I-MIP-1072 image data will be evaluated for visible uptake and compared with histopathology.

Conditions

Interventions

DRUG

123I-MIP-1072

Single IV dose

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Molecular Insight Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Peter Choyke, MD · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01279785 on ClinicalTrials.gov